搜尋
Teva Pharmaceutical Industries Ltd
TEVA添加自選
39.855USD
-0.205-0.51%
交易中 09/22, 11:25（美東）
46.43B總市值
32.37本益比TTM
關於 {index_name} Teva Pharmaceutical Industries Ltd 公司
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Teva Pharmaceutical Industries Ltd 簡介
公司代碼TEVA
公司名稱Teva Pharmaceutical Industries Ltd
上市日期Feb 06, 2087
CEOFrancis (Richard D)
員工數量33892
證券類型Depository Receipt
年結日Feb 06
公司地址124 Dvora Hanevi'a St.
城市TEL AVIV-YAFO
上市交易所NASDAQ OMX NASDAQ Basic NYSE
國家Israel
郵編6944020
電話97239148213
網址https://www.tevapharm.com/
公司代碼TEVA
上市日期Feb 06, 2087
CEOFrancis (Richard D)
Teva Pharmaceutical Industries Ltd公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Amir Elstein
Mr. Amir Elstein
Independent Director
Independent Director
2.12M
+0.68%
Mr. Richard D. Francis
Mr. Richard D. Francis
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.18M
+0.59%
Mr. Mark Sabag
Mr. Mark Sabag
Executive Vice President - International Markets Commercial
Executive Vice President - International Markets Commercial
885.93K
+11.77%
Dr. Sol J. Barer, Ph.D.
Dr. Sol J. Barer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
448.01K
+4.85%
Mr. Richard Daniell
Mr. Richard Daniell
Executive Vice President - European Commercial
Executive Vice President - European Commercial
183.56K
-16.34%
Dr. Eric A. Hughes
Dr. Eric A. Hughes
Executive Vice President - Global R&D, Chief Medical Officer
Executive Vice President - Global R&D, Chief Medical Officer
134.88K
+20.14%
Mr. Gerald M. (Jerry) Lieberman
Mr. Gerald M. (Jerry) Lieberman
Independent Director
Independent Director
130.15K
+11.13%
Mr. Evan Lippman
Mr. Evan Lippman
Executive Vice President - Business Development
Executive Vice President - Business Development
130.04K
+33.98%
Ms. Rosemary A. (Rose) Crane
Ms. Rosemary A. (Rose) Crane
Independent Director
Independent Director
127.74K
+11.35%
Dr. Perry D. Nisen, M.D., Ph.D.
Dr. Perry D. Nisen, M.D., Ph.D.
Independent Director
Independent Director
119.81K
+12.10%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Amir Elstein
Mr. Amir Elstein
Independent Director
Independent Director
2.12M
+0.68%
Mr. Richard D. Francis
Mr. Richard D. Francis
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.18M
+0.59%
Mr. Mark Sabag
Mr. Mark Sabag
Executive Vice President - International Markets Commercial
Executive Vice President - International Markets Commercial
885.93K
+11.77%
Dr. Sol J. Barer, Ph.D.
Dr. Sol J. Barer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
448.01K
+4.85%
Mr. Richard Daniell
Mr. Richard Daniell
Executive Vice President - European Commercial
Executive Vice President - European Commercial
183.56K
-16.34%
Dr. Eric A. Hughes
Dr. Eric A. Hughes
Executive Vice President - Global R&D, Chief Medical Officer
Executive Vice President - Global R&D, Chief Medical Officer
134.88K
+20.14%
常見問題
Teva Pharmaceutical Industries Ltd的前五大股東是誰？
Teva Pharmaceutical Industries Ltd的前五大股東如下：Mr. Amir Elstein
有多少機構持有Teva Pharmaceutical Industries Ltd(TEVA)的股份？
截至2026Q1，共有1226家機構持有Teva Pharmaceutical Industries Ltd的股份，合計持有的股份價值約為725.07M，占公司總股份的62.27% 。與2025Q4相比，機構持股有所增加，增幅為9191465.00。
哪個業務部門對Teva Pharmaceutical Industries Ltd的收入貢獻最大？
在2026Q1，Generic products業務部門對Teva Pharmaceutical Industries Ltd的收入貢獻最大，創收2.10B，占總收入的50.77% 。